Learn from three TAVR experts how patients and health systems are benefiting from the use of intravascular lithotripsy (IVL) to maintain safe transfemoral TAVR in patients with complicated vascular access. The experts share their experience with enabling early TAVR discharge protocols even in high risk and complex patients. The economic advantages can be significant: more efficient procedures and workflow, reductions in OR/hybrid lab/cath lab time, less ICU time and shorter hospital length of stay. Also hear how programs large and small are benefitting from new CMS inpatient and outpatient codes for IVL.

Expert Panel: 

Shockwave Panel

What You'll Learn: 

  • How IVL may be used to safely and simply facilitate transfemoral TAVR in a broad group of patients who may otherwise require alternative access procedures
  • What TAVR patients benefit most from IVL
  • Strategies Heart Teams are using to identify patients and enable minimalist TAVR, even with complicated vascular access
  • The latest trends from the TVT Registry update – and why IVL is being added to the registry to monitor usage
  • How IVL can be easily implemented in high and low volume programs
  • Tricks and tips to prevent vascular injury in TAVR
  • How recent reimbursement changes impact IVL procedures

Target Audience:

  • Chiefs/Directors of Cardiology, Cardiothoracic Surgery, Cardiac Surgery and Interventional Cardiology
  • Cardiothoracic Surgeons
  • Cardiac Surgeons
  • Interventional Cardiologists
  • Referring Cardiologists
  • Imaging Specialists
  • Cardiovascular Service Line Directors
  • Cardiology and Health System Administrators
  • Structural Heart Teams and Coordinators
  • TAVR Teams and Coordinators
  • OR and Cardiac Cath Lab Staff
  • Hospital C-Suite - COOs, CEOs, CFOs
  • Revenue Cycle